Q1 FY27 snapshot
Announcement Date31-Jul-26
Revenue (Top Line)₹663 Cr
Net Profit (Bottom Line)₹160 Cr
Earnings Per Share (EPS)₹13.04
Expenses₹503 Cr
Net profit margin (calculated)24.1%
Alivus Life Sciences Ltd. (ALIVUS) Quarterly Results: Q1 FY27
Quick answer: Alivus Life Sciences Ltd. (NSE: ALIVUS) reported Q1 FY27 revenue of ₹663 Cr and net profit of ₹160 Cr, with earnings per share (EPS) of ₹13.04, announced on 31-Jul-26.
That works out to a net profit margin of about 24.1% for the quarter.
Note: figures are pulled automatically from company filings and may lag or contain gaps. Verify on NSE or BSE. Not investment advice.
How to read Alivus Life Sciences Ltd.'s Q1 FY27 results
Revenue of ₹663 Cr is what Alivus Life Sciences Ltd. earned before costs. Net profit of ₹160 Cr is what remained for shareholders after expenses, interest and tax. Dividing one by the other gives a net margin of about 24.1%, a quick gauge of how much of each rupee of sales is kept as profit.
New to results? Read our guide on how to read quarterly results, see the full results list or the dividend calendar.
FAQs
Alivus Life Sciences Ltd. results FAQs
What were Alivus Life Sciences Ltd.'s Q1 FY27 results?
Alivus Life Sciences Ltd. (NSE: ALIVUS) reported Q1 FY27 revenue of ₹663 Cr and net profit of ₹160 Cr, with earnings per share (EPS) of ₹13.04, announced on 31-Jul-26.
What is Alivus Life Sciences Ltd.'s EPS for Q1 FY27?
Alivus Life Sciences Ltd.'s earnings per share for Q1 FY27 was ₹13.04. EPS is net profit divided by the number of outstanding shares.
When did Alivus Life Sciences Ltd. announce its Q1 FY27 results?
Alivus Life Sciences Ltd. announced its Q1 FY27 results on 31-Jul-26.
What is Alivus Life Sciences Ltd.'s net profit margin?
On the reported figures, Alivus Life Sciences Ltd.'s Q1 FY27 net profit margin is about 24.1% (net profit ÷ revenue).